DiaSorin
Update in progressDIA.MI (Milan)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDiagnostics & Research
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostic and molecular diagnostic tests worldwide. It offers immunodiagnostic assays for infectious diseases, endocrinology, GI infections, autoimmunity, hypertension, sepsis, bone metabolism, and oncology under the LIAISON XL/XS platforms. It also markets Simplexa CMV direct kit (saliva/urine), LIAISON PLEX Respiratory Flex and Yeast Blood Culture Assays, and the xMAP technology platform. Founded in 1968, based in Saluggia, Italy.
Company score
- Sentiment
- 0.38
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.43
- Governance
- 0.00
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.13
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.26
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!